Denmark· DK-28101697094
Centyl Mite med Kaliumklorid
A bendroflumethiazide and potassium product containing bendroflumethiazid, kaliumchlorid, registered in Denmark by Karo Pharma AB. The same ATC class is registered in 5 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Bendroflumethiazide and potassium is registered in 5 of 19 countries.
Countries holding a registration under ATC C03AB01 (bendroflumethiazide and potassium), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 2 of them publish a price we can compare per daily dose
Bendroflumethiazide and potassium · ATC C03AB01
5 / 19 countries
- Denmark
- Icelandprice
- Ireland
- Norwayprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- BENDROFLUMETHIAZID, KALIUMCHLORID
- Manufacturer
- Karo Pharma AB
- Country
- Denmark (DK)
- ATC code
- C03AB01
- ATC class
- Bendroflumethiazide and potassium
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101697094
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C03AB01
Bendroflumethiazide and potassium, as other registers publish it.
- DenmarkBendrozaTeva B.V.
- NorwayBendrozaTeva B.V.
- DenmarkBendrozaTeva B.V.
- IrelandCentyl K 2.5 mg/573 mg modified-release tabletsKaro Pharma AB
- United KingdomCentyl K modified-release tabletsLEO Pharma
- NorwayCentyl med kaliumkloridKaro Pharma AB (1)
- DenmarkCentyl med KaliumkloridKaro Pharma AB
- IcelandCentyl með kaliumkloridKaro Pharma AB*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce45b525-a8d7-4907-9b86-80e6132d4699 GET /v1/drugs/ce45b525-a8d7-4907-9b86-80e6132d4699?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "overtrukne tabletter",
"source": "dkma",
"strength": "1,25+573 mg",
"auth_role": "DKMA",
"dk_drugid": "28101697094",
"substance": "BENDROFLUMETHIAZID, KALIUMCHLORID",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "34829"
}See everything about bendroflumethiazide and potassium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.